Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,760 public trials 2,246 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Recruiting

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

NCT06838845

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • The First Affiliated Hospital, Sun-Yat Sen University /ID# 272997 Guangzhou, Guangdong, China
  • The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 274753 Guangzhou, Guangdong, China
  • The Second Affiliated Hospital Of Zhengzhou University /ID# 274754 Zhengzhou, Henan, China
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions
Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

NCT07244705

Conditions
Colonic Diseases, Colorectal Cancer (CRC), Colorectal Cancer (Diagnosis), +15 more
Locations
  • Liverpool Cancer Therapy Centre Liverpool, New South Wales, Australia
  • Macquarie University Hospital (MUH) Macquarie Park, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Greenslopes Private Hospital - Cyril Gilbert Cancer Centre Greenslopes, Queensland, Australia
View all 15 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details

Related conditions